Cannapharmarx (CPMD) has released an update.
CannaPharmaRx is gearing up for rapid growth, with ambitions to become a leader in advanced cannabis cultivation and to achieve over $10 million CDN in 2024 revenue by expanding distribution globally. The CEO has outlined strategic initiatives, including strengthening the board with expert members, streamlining licensing processes, and ensuring product pre-sales through partnerships. These efforts are set to propel the company toward a projected revenue target of $40-$50 million in the coming years.
For further insights into CPMD stock, check out TipRanks’ Stock Analysis page.
